Pregnancy hypertensive disorders (PHDs) are considered to be a multifactorial and multisystemic disorder with a genetic predisposition. Alterations in the renin-angiotensin system are considered to play a significant role in the pathogenesis of the PHDs. However, results from published studies on the association between the angiotensin II type-1 receptor (AT1R) A1166C (rs5186) gene polymorphism and the risk of PHDs are conflicting. The aim of this meta-analysis was to investigate whether an association exists between AT1R A1166C gene polymorphism and PHDs in epidemiologic studies. We searched the PubMed, China National Knowledge Infrastructure (CNKI), and Chinese Biomedicine Literature (CBM) databases from their inception to July 2012. A total of 18 case-control studies, including a total of 1635 cases and 1934 controls, were available for this analysis. A significantly positive correlation was observed between the C allele and the AC/CC genotypes with PHDs in an overall comparison. In the subgroup analysis by ethnicity, the results suggested that the C allele and the AC/CC genotypes were associated with risk of PHDs in Asians. Our findings indicate that the AT1R gene 1166C allele and the AC/CC genotypes were positively associated with the PHDs, especially in Asians. However, well-designed multicenter studies with a larger sample size should be conducted to confirm the results.
Introduction
Pregnancy hypertensive disorders (PHDs), mainly including gestational hypertension (GH), pre-eclampsia (PE), severe pre-eclampsia and eclampsia, are a major contributor to maternal, fetal, and neonatal morbidity and mortality. 1 PHDs have been estimated to complicate 5% of all pregnancies and 11% of first pregnancies, half associated with PE, and accounting for up to 40,000 maternal deaths annually. 2 Previous studies showed that PHDs were the cause of 16.1% of maternal deaths in developed countries, 9.1% in Africa, 9.1% in Asia, and 25.7% in Latin America and the Caribbean, respectively. 3 More and more studies have revealed PHDs to be a multifactorial disease, the complex combination of environmental factors and several predisposing genes whose products likely interact with each other. 2, 4 The renin-angiotensin system (RAS) plays a central role in blood pressure regulation during pregnancy, which may affect the risk of GH and PE. 5 Angiotensin II, the major biologically active component of the RAS, exerts its effects via two distinct subtypes of angiotensin II receptors, angiotensin II type-1 receptor (AT1R) and angiotensin II type-2 receptor (AT2R). The majority of angiotensin II's actions are believed to occur via AT1R, including growth promotion, vasoconstriction, anti-natriuresis, aldosterone secretion, inhibition of renin biosynthesis and release, salt appetite, thirst, and sympathetic outflow. 6, 7 The human AT1R gene consists of five exons and spans over 55 kb on chromosome 3q21-25. The AT1R protein belongs to a seven transmembrane G-protein-coupled receptor family. AT1R is expressed in vascular smooth muscle cells and the adrenal glands in pregnancy. 8 It is coupled to the Gq protein to increase intracellular calcium. 9 Several polymorphic sites have been identified in the AT1R gene, and one transversion biallelic polymorphism in particular, A1166C (rs5186), in the 3′ untranslated region has been extensively studied. Recently, a number of case-control studies were conducted to investigate the association between AT1R A1166C polymorphism and PHD risk. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] However, studies of these polymorphisms reported both positive 10, 11, 13, 16, 19 and negative association with PHDs. 12, 14, 15, 17, 18 Hence, the cumulative results of these reports are conflicting rather than conclusive.
Although a meta-analysis showed no association between AT1R A1166C polymorphism and PE, 20 there has been no meta-analysis on the association of PHDs with the A1166C polymorphism. Therefore, we performed this meta-analysis with accumulated data to evaluate the association between the AT1R A1166C polymorphism and susceptibility to PHDs.
Materials and methods

Publication search
We searched the PubMed, CNKI (China National Knowledge Infrastructure) and Chinese Biomedicine Literature (CBM) databases for all articles on the association between AT1R gene A1166C polymorphism and PHD risk (last search updated on 10 July 2012), and we adopted a search strategy combining the terms '(pregnancy hypertensive disorders OR pregnancy-induced hypertension OR hypertensive disorders in pregnancy OR gestational proteinuric hypertension OR gestational hypertension OR pre-eclampsia OR eclampsia) AND (angiotensin II type I receptor OR angiotensin II receptor type I OR AT1R OR A1166C OR A1166>C OR rs5186)'. The search was conducted without limitation on language. Additional studies were identified by hands-on searches from original study references or articles reviewing this topic. If studies had partially overlapping subjects, the latest sample size was selected for the analysis. All available data were independently extracted by two investigators, and any inconsistencies were resolved by discussions with the third investigator.
Inclusion and exclusion criteria
We reviewed abstracts of all citations and retrieved studies. In our meta-analysis, the inclusion criteria for studies were: (a) case-control studies conducted to assess the association between AT1R A1166C polymorphism and PHD risk; (b) presence of useful genotype frequency to calculate the odds ratio (OR); (c) clear description of PHD diagnoses and the sources of cases and controls; (d) all the genotype distributions in the controls should meet Hardy-Weinberg equilibrium (HWE); and (e) the study was published in English or Chinese. Major reasons for exclusion of studies were: (a) duplicate data; (b) abstract, comment, review, or editorial; (c) insufficient data were reported; (d) women who were hypertensive or had proteinuria prior to the 20th week of pregnancy were excluded, as were those with essential hypertension, diabetes, renal or cardiac disease, or a current multiple pregnancy. The diagnostic criteria were applied for GH, PE and eclampsia. 21 
Data extraction and quality assessment
Data extraction was independently done by two investigators (Zhang LS and Qin HJ), and discrepancies were resolved by consensus including a third investigator (Zhang K). The following characteristics were collected from each study: first author, the year of publication, country/region of the study population, ethnicity, number of cases and controls, minor allele frequency (MAF) in controls, and evidence of HWE. The frequencies of the alleles and the genotypic distributions were extracted or calculated for both cases and controls. For studies including subjects of different ethnic groups, data were extracted separately for each ethnic group whenever possible. Different ethnicities were categorized as Asian or Caucasian.
Statistical analysis
HWE was assessed by Fisher's exact test, and p < 0.05 was considered as significant disequilibrium. The strength of the association between PHDs and the AT1R A1166C polymorphism was estimated using OR, with the corresponding 95% confidence interval (CI). The pooled ORs were performed for an allele comparison (C vs. A) and a dominant model (AC+CC vs. AA). We also carried out stratified analyses by ethnicity and PE in the studies. A chi-square-based Q test was performed to check the heterogeneity. 22 If the result of the heterogeneity test was p > 0.05, then ORs were pooled according to the fixed-effects model (the Mantel-Haenszel model). 23 Otherwise, the random effects model (the DerSimonian-Laird model) was used. 24 To explore sources of heterogeneity across studies, we performed logistic meta-regression analyses, and examined the following study characteristics: ethnicity, publication year, C allele frequency in control, and study sample size. Publication bias was checked using the Begg test 25 and the Egger test. 26 Sensitivity analyses were performed to assess the stability of the result with each study in turn being removed. All statistical tests were performed using STATA version 11.0 software (Stata Corporation, College station, TX).
Results
Characteristics of studies
Our initial search identified 86 studies according to the search words, and one record added through the reference scan. 14 After screening the title and reading the abstract, we excluded 64 studies for not meeting the eligibility criteria. After reading the full text, we excluded another two studies, one because the study population was monomorphic at this site 27 and the other because of lack of gene frequency data to calculate the ORs and 95% CI. 28 Two studies were excluded for disequilibrium distribution of genotype in the controls. 29, 30 One study was excluded because the recruited subjects presented with clinical signs of PE prior to 20 weeks of gestation. 31 Finally, 18 studies (seven in English 10, 12, 14, 15, 17, 18, 32 and 11 in Chinese, 10, 13, 16, 19, [33] [34] [35] [36] [37] [38] [39] four of which were the dissertations of postgraduate students) including 1635 cases and 1934 controls were available for this analysis. Sample sizes of the 18 studies ranged from 60 to 310. The study selection process is presented in Figure 1 and all study characteristics are listed in Table 1 . Thirteen of the eligible studies analyzed Asian patients and five studies analyzed Caucasian patients. PHD types were distributed as follows: 11 studies were concerned with PE, one study with GH separately, 11 two studies with GH and PE separately, 16, 17 and six studies with GH, PE and eclampsia. 10, 13, [33] [34] [35] 39 
Quantitative synthesis
For control subjects, the minor allele frequency of the C allele ranged from 0.022 to 0.333 in Asians and from 0.230 to 0.291 in Caucasians. The evaluation of the association of AT1R A1166C polymorphism with PHD risk is shown in Figures 2 to 5 . The C allele and the AC/CC genotypes were associated with a significantly increased risk of PHDs by a random effects model (OR = 1.577, 95% CI = 1.210-2.056 for C vs. A; OR = 1.663, 95% CI = 1.222-2.263 for AC/CC vs. AA, respectively). In the subgroup analysis by ethnicity, the results suggested that the C allele and the AC/CC genotypes were associated with risk of PHD development in Asians (OR = 1.885, 95% CI = 1.278-2.780 for C vs. A; OR = 2.020, 95% CI = 1.320-3.091 for AC/CC vs. AA, respectively). However, no elevated risk of PHDs was found in Caucasians (OR = 1.160, 95% CI = 0.930-1.448 for C vs. A; OR = 1.137, 95% CI = 0.887-1.458 for AC/CC vs. AA, respectively). Moreover, when stratified by the type of PHDs with PE, no significant association between PE and the AT1R A1166C polymorphism was observed in all PE patients (OR = 1.191, 95% CI = 0.948-1.496 for C vs. A; OR = 1.240, 95% CI = 0.939-1.636 for AC/CC vs. AA, respectively). Similar results were found among Asians (OR = 1.386, 95% CI = 0.907-2.118 for C vs. A; OR = 1.467, 95% CI = 0.906-2.373 for AC/CC vs. AA, respectively) and Caucasians (OR = 1.117, 95% CI = 0.881-1.416 for C vs. A; OR = 1.112, 95% CI =0.823-1.502 for AC/CC vs. AA, respectively).
Heterogeneity analysis
There was heterogeneity among studies in overall comparisons (p < 0.001, I 2 = 69.3% for C vs. A; p < 0.001, I 2 = 72.4% for AC/CC vs. AA, respectively). To explore the sources of heterogeneity, we performed meta-regression analysis for allele comparison (C vs. A) and dominant model comparison (AC/CC vs. AA) by evaluating the study characteristics of ethnicity, publication year, and study sample size ( ≤ 200 subjects or >200 subjects). As a result, C allele frequency in control (p = 0.31 for allele comparison) and AC/CC genotype frequency in the control group (p = 0.005 for dominant genetic model comparison) could explain 91.44% (C vs. A) and 58.67% (AC/CC vs. AA) of the heterogeneity, respectively. But ethnicity, publication year, and study sample size were not found to contribute substantially to heterogeneity.
Sensitivity analysis and publication bias
To evaluate the effect of individual studies on the overall meta-analysis estimate, we excluded one study at a time, and the omission of any single study made no significant difference, suggesting that the results of this meta-analysis were stable. Begg's funnel plot and Egger's test were performed to assess publication bias of the selected literature. No evidence of publication bias in our study was observed (C vs.
A: Begg's test p = 0.069, Egger's test p = 0.054; dominant model: Begg's test p = 0.150, Egger's test p = 0.175, respectively).
Discussion
This study aimed to explore the association of the AT1R A1166C polymorphism with PHD risk among a total of 3569 subjects via a meta-analysis. We demonstrated that the presence of the AT1R gene 1166C allele and the AC/CC genotypes were significantly associated with the PHDs. In the subgroup analysis by ethnicity, the results suggested that the C allele and the AC/CC genotypes increased the risk of PHD development in Asians. Nevertheless, no elevated risk between C allele and the AC/CC genotypes with PHDs was found in the Caucasians. Moreover, when stratified by type of PHDs with PE, no association between PE and the AT1R A1166C polymorphism was observed.
In the present meta-analysis, we observed a wide divergence of the AT1R A1166C C allele frequency among different ethnic populations, even within the same ethnicity. As shown in Table 1 , the AT1R A1166C C allele frequency in Chinese populations of different regions ranged from 0.022 to 0.333. The frequency in three Chinese populations was remarkably lower than that in other Chinese populations (Table 1) , 10, 19, 35 suggesting that some environmental factors such as living habits and diets may contribute to genetic profiles. In addition, we also noted the obvious differences in the effect of the AT1R A1166C C allele between the Asian group and the Caucasian group. The differences might be due to the discrepant genetic composition between these ethnic populations, environmental factors and lifestyle backgrounds. Furthermore, as simulated by a recent data-mining investigation, differences in allele frequency can result in a reversal of allelic effects in which a protective allele becomes a risk factor in replication studies; 40 this seems to be a possible explanation for divergent results in the Asian populations. Thus, it is reasonable to speculate that the AT1R A1166C polymorphism may have pleiotropic effects on the etiology of PHDs among different ethnic or regional groups.
In this meta-analysis, obvious heterogeneity between studies was observed in overall comparisons and subgroup analyses, and then meta-regression analysis was used to explore sources of heterogeneity. The results indicated that C allele frequency and AC/CC genotype quantity of the control group were potential sources of heterogeneity. Therefore, further studies using larger numbers of participants from multiple different regions should be conducted. Furthermore, in the current study, Begg's funnel plot and Egger's test were used to evaluate publication bias. Neither the shape of the funnel plots nor the statistical results showed publication bias. When the sensitivity analysis was performed, the results implied our findings were reliable.
However, there were still some limitations in this metaanalysis. First, in several studies the type of the PHDs was not identified. Thus, we did not enter all types of PHDs into subgroup analysis, which may have masked associations in certain clinical subgroups. Second, the C allele frequency of AT1R A1166C in the control groups varied greatly, especially in the Asian population, which contributed a potential source of considerable heterogeneity. The substantial heterogeneity adds difficulties and uncertainty to the interpretation of our results. Third, the populations included in this metaanalysis were mainly composed of Asians and European Caucasians. Since population-based surveys have found that Latin American and Caribbean countries are the regions with highest incidence of PHDs, 3 lack of data from those areas may have led to conflicting and misleading results. In spite of these limitations, this meta-analysis also had advantages. First, we extracted data from as many different studies as possible, which significantly increased the statistical power of this meta-analysis. Second, the quality of case-control studies included in this meta-analysis met our selection criteria well. Third, no publication bias was found, which leads to a possibly robust result.
In conclusion, our study expands upon previous findings on PE by showing that the presence of AT1R gene A1166C C allele or AC/CC genotype was associated with an increased risk of PHDs. Since the studies were limited to Asians and European Caucasians, it is critical that larger and well-designed multicenter studies based on Latin American and Caribbean countries should be performed to re-evaluate the association. Moreover, additional longitudinal studies examining gene-gene or gene-environment interactions, as well as studies seeking to provide biological or clinical confirmation of our results, are warranted.
